Maxcyte Stock Price History
| MXCT Stock | USD 3.43 0.19 5.25% |
If you're considering investing in MaxCyte Stock, it is important to understand the factors that can impact its price. As of today, the current price of MaxCyte stands at 3.43, as last reported on the 27th of February, with the highest price reaching 3.53 and the lowest price hitting 3.38 during the day. Currently, MaxCyte is moderately volatile. MaxCyte has Sharpe Ratio of close to zero, which conveys that the firm had a close to zero % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for MaxCyte, which you can use to evaluate the volatility of the firm. Please verify MaxCyte's Downside Deviation of 2.91, risk adjusted performance of 0.0549, and Mean Deviation of 2.88 to check out if the risk estimate we provide is consistent with the expected return of 0.0123%.
At this time, MaxCyte's Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 323.9 M in 2025, whereas Capital Stock is likely to drop slightly above 905.1 K in 2025. . At this time, MaxCyte's Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 1.98 in 2025, despite the fact that Price Earnings To Growth Ratio is likely to grow to (0.15). MaxCyte Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
MaxCyte |
Sharpe Ratio = 0.0032
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MXCT |
Estimated Market Risk
| 3.83 actual daily | 34 66% of assets are more volatile |
Expected Return
| 0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average MaxCyte is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MaxCyte by adding MaxCyte to a well-diversified portfolio.
Price Book 1.7506 | Enterprise Value Ebitda (11.07) | Price Sales 8.6685 | Shares Float 94.8 M | Wall Street Target Price 9.25 |
MaxCyte Stock Price History Chart
There are several ways to analyze MaxCyte Stock price data. The simplest method is using a basic MaxCyte candlestick price chart, which shows MaxCyte price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 21, 2025 | 5.1 |
| Lowest Price | February 27, 2025 | 3.43 |
MaxCyte February 27, 2025 Stock Price Synopsis
Various analyses of MaxCyte's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell MaxCyte Stock. It can be used to describe the percentage change in the price of MaxCyte from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of MaxCyte Stock.| MaxCyte Price Rate Of Daily Change | 0.95 | |
| MaxCyte Price Action Indicator | (0.12) | |
| MaxCyte Price Daily Balance Of Power | (1.27) | |
| MaxCyte Accumulation Distribution | 26,630 |
MaxCyte February 27, 2025 Stock Price Analysis
MaxCyte Stock Price History Data
The price series of MaxCyte for the period between Fri, Nov 29, 2024 and Thu, Feb 27, 2025 has a statistical range of 1.87 with a coefficient of variation of 10.81. The daily prices for the period are spread out with arithmetic mean of 4.18. The median price for the last 90 days is 4.19.| Open | High | Low | Close | Volume | ||
| 02/27/2025 | 3.53 | 3.53 | 3.38 | 3.43 | 626,701 | |
| 02/27/2025 | 3.53 | 3.53 | 3.38 | 3.43 | 626,701 | |
| 02/25/2025 | 3.78 | 3.97 | 3.60 | 3.62 | 603,796 | |
| 02/24/2025 | 3.91 | 3.96 | 3.77 | 3.77 | 275,513 | |
| 02/21/2025 | 4.02 | 4.08 | 3.81 | 3.85 | 348,701 | |
| 02/20/2025 | 3.96 | 4.04 | 3.92 | 3.96 | 237,128 | |
| 02/19/2025 | 3.99 | 4.06 | 3.94 | 3.97 | 282,454 | |
| 02/18/2025 | 4.19 | 4.21 | 3.96 | 4.02 | 553,902 | |
| 02/14/2025 | 4.10 | 4.32 | 4.10 | 4.17 | 538,476 | |
| 02/13/2025 | 4.27 | 4.29 | 4.07 | 4.07 | 277,556 | |
| 02/12/2025 | 4.11 | 4.22 | 4.06 | 4.20 | 332,424 | |
| 02/11/2025 | 4.28 | 4.34 | 4.11 | 4.14 | 345,011 | |
| 02/10/2025 | 4.42 | 4.42 | 4.22 | 4.36 | 405,680 | |
| 02/07/2025 | 4.46 | 4.49 | 4.36 | 4.39 | 424,468 | |
| 02/06/2025 | 4.67 | 4.67 | 4.45 | 4.48 | 330,839 | |
| 02/05/2025 | 4.55 | 4.63 | 4.48 | 4.62 | 349,509 | |
| 02/04/2025 | 4.32 | 4.51 | 4.26 | 4.50 | 338,424 | |
| 02/03/2025 | 4.38 | 4.47 | 4.26 | 4.35 | 416,744 | |
| 01/31/2025 | 4.59 | 4.74 | 4.50 | 4.51 | 419,515 | |
| 01/30/2025 | 4.74 | 4.90 | 4.58 | 4.59 | 627,778 | |
| 01/29/2025 | 4.75 | 4.90 | 4.53 | 4.64 | 502,477 | |
| 01/28/2025 | 4.52 | 4.74 | 4.47 | 4.68 | 907,867 | |
| 01/27/2025 | 4.52 | 4.73 | 4.49 | 4.52 | 643,353 | |
| 01/24/2025 | 4.72 | 4.85 | 4.60 | 4.66 | 682,308 | |
| 01/23/2025 | 5.02 | 5.12 | 4.67 | 4.76 | 972,330 | |
| 01/22/2025 | 5.07 | 5.14 | 4.98 | 5.06 | 440,293 | |
| 01/21/2025 | 5.05 | 5.20 | 4.95 | 5.10 | 895,932 | |
| 01/17/2025 | 4.81 | 5.02 | 4.74 | 4.94 | 648,042 | |
| 01/16/2025 | 4.84 | 4.96 | 4.64 | 4.75 | 629,833 | |
| 01/15/2025 | 4.81 | 4.92 | 4.68 | 4.82 | 702,197 | |
| 01/14/2025 | 4.85 | 5.09 | 4.56 | 4.64 | 1,018,515 | |
| 01/13/2025 | 4.33 | 4.96 | 4.33 | 4.91 | 1,215,372 | |
| 01/10/2025 | 4.45 | 4.46 | 4.22 | 4.40 | 521,342 | |
| 01/08/2025 | 4.33 | 4.63 | 4.24 | 4.57 | 791,926 | |
| 01/07/2025 | 4.28 | 4.41 | 4.14 | 4.38 | 761,085 | |
| 01/06/2025 | 4.40 | 4.48 | 4.25 | 4.30 | 389,554 | |
| 01/03/2025 | 4.19 | 4.47 | 4.18 | 4.39 | 291,165 | |
| 01/02/2025 | 4.02 | 4.25 | 4.01 | 4.15 | 438,072 | |
| 12/31/2024 | 4.16 | 4.38 | 4.07 | 4.16 | 345,521 | |
| 12/30/2024 | 4.18 | 4.18 | 4.05 | 4.11 | 309,026 | |
| 12/27/2024 | 4.04 | 4.19 | 3.97 | 4.13 | 365,564 | |
| 12/26/2024 | 4.00 | 4.11 | 4.00 | 4.07 | 258,256 | |
| 12/24/2024 | 4.05 | 4.12 | 3.97 | 4.11 | 199,830 | |
| 12/23/2024 | 4.17 | 4.21 | 3.98 | 4.06 | 316,063 | |
| 12/20/2024 | 4.02 | 4.41 | 4.02 | 4.24 | 923,443 | |
| 12/19/2024 | 4.19 | 4.26 | 3.98 | 4.14 | 537,631 | |
| 12/18/2024 | 4.30 | 4.55 | 4.11 | 4.19 | 457,724 | |
| 12/17/2024 | 4.37 | 4.47 | 4.25 | 4.27 | 483,170 | |
| 12/16/2024 | 4.25 | 4.42 | 4.23 | 4.39 | 415,005 | |
| 12/13/2024 | 4.31 | 4.36 | 4.09 | 4.28 | 408,413 | |
| 12/12/2024 | 4.42 | 4.47 | 4.22 | 4.34 | 353,306 | |
| 12/11/2024 | 4.14 | 4.45 | 4.14 | 4.43 | 500,547 | |
| 12/10/2024 | 4.17 | 4.25 | 4.10 | 4.19 | 971,790 | |
| 12/09/2024 | 3.66 | 4.35 | 3.65 | 4.17 | 990,359 | |
| 12/06/2024 | 3.61 | 3.71 | 3.58 | 3.60 | 294,691 | |
| 12/05/2024 | 3.65 | 3.68 | 3.58 | 3.58 | 494,651 | |
| 12/04/2024 | 3.58 | 3.70 | 3.53 | 3.67 | 443,240 | |
| 12/03/2024 | 3.63 | 3.63 | 3.50 | 3.58 | 628,607 | |
| 12/02/2024 | 3.57 | 3.70 | 3.53 | 3.63 | 657,000 | |
| 11/29/2024 | 3.55 | 3.62 | 3.46 | 3.55 | 355,243 | |
| 11/27/2024 | 3.38 | 3.58 | 3.38 | 3.52 | 776,537 |
About MaxCyte Stock history
MaxCyte investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for MaxCyte is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in MaxCyte will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing MaxCyte stock prices may prove useful in developing a viable investing in MaxCyte
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 118.8 M | 66.8 M | |
| Net Loss | -21.2 M | -22.3 M |
MaxCyte Quarterly Net Working Capital |
|
MaxCyte Stock Technical Analysis
MaxCyte technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
MaxCyte Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for MaxCyte's price direction in advance. Along with the technical and fundamental analysis of MaxCyte Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of MaxCyte to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0549 | |||
| Jensen Alpha | 0.2306 | |||
| Total Risk Alpha | 0.2651 | |||
| Sortino Ratio | 0.0819 | |||
| Treynor Ratio | (1.38) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for MaxCyte Stock Analysis
When running MaxCyte's price analysis, check to measure MaxCyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MaxCyte is operating at the current time. Most of MaxCyte's value examination focuses on studying past and present price action to predict the probability of MaxCyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MaxCyte's price. Additionally, you may evaluate how the addition of MaxCyte to your portfolios can decrease your overall portfolio volatility.